The GLP-1 pills are tablets you swallow, while the injectable versions are given with a syringe, usually in the upper arm, thigh, or abdomen (the belly area)
February 2026: Eli Lilly reported that orforglipron, its once-daily oral GLP-1 receptor agonist, is being evaluated in Phase III studies for weight management in adults with obesity or overweight with at least one weight-related medical condition
Cagrilintide is a long-acting amylin analogue known for activating multiple receptors within the amylin/calcitonin family
It should not be used as a drug, supplement, treatment, wellness product, or personal-use product
The FTC has signaled a zero-tolerance policy for product hopping as presumptive anticompetitive conduct under the current administration, and proposed legislation would grant the FTC express authority to prosecute product hopping
Injection Administration and Timing While Traveling Tirzepatide is typically dosed once weekly on the same day each week